The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program
Open accessAbstract
As part of the ongoing multinational SENTRY antimicrobial resistance surveillance program, a total of 1,047 respiratory tract isolates of Streptococcus pneumoniae, 845 from 27 United States medical centers and 202 from seven Canadian institutions, were collected between February and June 1997 and characterized in a central laboratory. In the United States, the overall percentages of penicillin-intermediate strains and strains with high-level resistance to penicillin were 27.8% and 16.0%, respectively. In Canada, these values were 21.8% and 8.4%, respectively. Among the 31 centers in the United States and Canada that contributed at least 19 isolates, the combined rate of intermediate plus resistant strains varied between 24.0% and 67.8%. The in vitro activity of 19 other antimicrobials was assessed against all study isolates. Overall rates of resistance among selected agents in the United States and Canada, respectively, were as follows: amoxicillin, 18.1% and 10.5%; cefaclor, 38.3% and 26.2%; cefuroxime, 19.5% and 12.9%; cefpodoxime, 18.6% and 11.4%; cefepime, 8.2% and 4.5%; cefotaxime, 4.0% and 3.0%; macrolides (i.e., erythromycin, azithromycin, and clarithromycin), 11.7%-14.3% and 5.0%-7.4%; clindamycin, 3.5% and 3.5%; chloramphenicol, 3.9% and 4.0%; tetracycline, 10.2% and 10.9%; and trimethoprim-sulfamethoxazole, 19.8% and 15.8%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F., Martin, R., & Gudiol, F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330802 · Cited by 773
Emergence of Multiply Resistant Pneumococci
Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B., Witcomb, M. A., Isaäcson, M., Ward, J. I., et al. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991402 · Cited by 630
Doern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482
Self-citationJorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W., & Redding, J. S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2075 · Cited by 310
Self-citationAntimicrobial Resistance of Streptococcus pneumoniae in the United States, 1979-1987
Spika, J. S., Facklam, R. R., Plikaytis, B. D., Oxtoby, M. J., & Pneumococcal Surveillance Working Group (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1273 · Cited by 261
Sloas, M. M., Ff, B., Chesney, P. J., Bk, E., Bc, H., Tenover, F. C., & Rj, L. (1992) · PubMed · Cited by 258
Grebe, T., & Hakenbeck, R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.829 · Cited by 241
Friedland, I. R., Paris, M., Ehrett, S., Hickey, S., Olsen, K., & McCracken, G. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1630 · Cited by 233
Cited by
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
The Diagnosis and Management of Acute Otitis Media
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson, M. A., Joffe, M. D., Miller, D. T., Rosenfeld, R. M., Sevilla, X. D., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3488 · Cited by 1,442
Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Chen, D. K., McGeer, A., de Azavedo, J. C., & Low, D. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410403 · Cited by 987
Diagnosis and Management of Acute Otitis Media
Media, S. O. M. O. A. O. (2004) · Pediatrics · doi:10.1542/peds.113.5.1451 · Cited by 902
Reducing Antibiotic Use in Children: A Randomized Trial in 12 Practices
Finkelstein, J. A., Davis, R. L., Dowell, S. F., Metlay, J. P., Soumerai, S. B., Rifas-Shiman, S. L., Higham, M., Miller, Z., Miroshnik, I., Pedan, A., et al. (2001) · Pediatrics · doi:10.1542/peds.108.1.1 · Cited by 674
Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., Hyland, R. H., & and the Canadian Community-Acquired Pneumonia Working Group (2000) · Clinical Infectious Diseases · doi:10.1086/313959 · Cited by 664
Heffelfinger, J. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1399 · Cited by 610
Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K., & Group, T. S. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1762 · Cited by 539
Self-citationMolecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525
Resistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
Clinical Practice Guideline: Management of Sinusitis
Subcommittee on Management of Sinusitis and Committee on Quality Improvement (2001) · Pediatrics · doi:10.1542/peds.108.3.798 · Cited by 409
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378
Self-citationDiekema, D. J., & Jones, R. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06964-1 · Cited by 378
Self-citationHoban, D. J., Doern, G. V., Fluit, A. C., Roussel‐Delvallez, M., & Jones, R. N. (2001) · Clinical Infectious Diseases · doi:10.1086/320181 · Cited by 375
Self-citationMacrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates
Hyde, T. B. (2001) · JAMA · doi:10.1001/jama.286.15.1857 · Cited by 315
Review of Macrolides and Ketolides: Focus on Respiratory Tract Infections
Zhanel, G. G., Dueck, M., Hoban, D. J., Vercaigne, L. M., Embil, J. M., Gin, A. S., & Karlowsky, J. A. (2001) · Drugs · doi:10.2165/00003495-200161040-00003 · Cited by 304
Thornsberry, C., Jones, M. E., Hickey, M. L., Mauriz, Y., Kahn, J., & Sahm, D. F. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.6.749 · Cited by 300
Kim, L., McGee, L., Tomczyk, S., & Beall, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-15 · Cited by 285
In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid)
Andes, D., van Ogtrop, M. L., Peng, J., & Craig, W. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3484-3489.2002 · Cited by 278
Metlay, J. P., Hofmann, J., Cetron, M. S., Fine, M. J., Farley, M. M., Whitney, C., & Breiman, R. F. (2000) · Clinical Infectious Diseases · doi:10.1086/313716 · Cited by 270
VAN ZUIJLEN, D. A., SCHILDER, A. G. M., VAN BALEN, F. A. M., & HOES, A. W. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00004 · Cited by 262
Resistance among Streptococcus pneumoniae:Implications for Drug Selection
Appelbaum, P. C. (2002) · Clinical Infectious Diseases · doi:10.1086/340400 · Cited by 260
Metadata
- Authors
- Doern, G. V., Pfaller, M. A., Kugler, K., Freeman, J., & Jones, R. N.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-10
- Volume
- 27
- Issue
- 4
- Pages
- 764-770
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2138445568
- Cited by
- 386
- References
- 18
- FWCI
- 52.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.